天麻通脑饮治疗急性脑梗死痰瘀阻络证的临床疗效观察  

Clinical observation on treatment of phlegm network symptoms in acute cerebral infarction with Tianmatongnao decoction

作　　者：江淑婷[1] 吴明华[2] 

机构地区：[1]南京中医药大学,210029 [2]南京中医药大学附属江苏省中医院

出　　处：《疑难病杂志》2011年第5期328-330,共3页Chinese Journal of Difficult and Complicated Cases

基　　金：江苏省中医药领军人才培养项目(No.LJ200912)

摘　　要：目的观察天麻通脑饮治疗脑梗死痰瘀阻络证的临床疗效。方法将138例急性脑梗死患者随机分为治疗组(69例)和对照组(69例),对照组给予常规基础治疗,治疗组在常规治疗的基础上加服天麻通脑饮,21d后观察患者临床疗效及NIHSS评分、Barthel指数变化,记录不良反应。结果治疗组有效率(92.7%)高于对照组(76.8%),差异有统计学意义(P<0.05)。治疗后第14、21天2组NIHSS评分较治疗前显著降低、Barthel指数较治疗前显著增高(P均<0.01);且治疗第21天时治疗组NIHSS评分较对照组显著降低、Barthel指数较对照组显著增高(P均<0.01)。2组均未发生不良反应。结论天麻通脑饮治疗脑梗死痰瘀阻络证有较好的临床疗效。Objective To observe the clinical efficacy of Tianmatongnao decoction in the treatment of phlegm network symptoms in acute cerebral infarction.Methods Totally 138 patients with acute cerebral infarction were randomly divided into treatment group（69 cases） and control group（69 cases）,on the basis of conventional therapy,the treatment group was administrated Tianmatongnao decoction.After 21 days,the clinical efficacy,the NIHSS score,Barthel Index change were observed and compared,the side effect was recorded.Results The markedly effective rate was 92.7%in treatment group,which was higer than that in control group（76.8%）,there was significant differences（P0.05）.The NIHSS score in two group were significantly lower than that before treatment,Barthel index was significantly higher than that before treatment at 14 d and 21 d after treatment（P0.01）,furthermore,the effects were more obviously in treatment group at 21d（P0.01 ）.No seriously side effects was observed.Conclusion It demonstrated that the Tianmatongnao decoction had well clinical efficacy in treatment of brain infarction phlegm.

关 键 词：脑梗死 急性 痰瘀阻络 天麻通脑饮 

分 类 号：R277.7[医药卫生—中医学]